Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calbonate is a veterinary pharmaceutical product developed by **Pure Med Farma**, primarily used in the management of metabolic disorders in livestock. It is marketed in a 450 ml vial, a presentation standard for the treatment of acute hypocalcemia, commonly known as **milk fever** or parturient paresis, in cattle, buffalo, and other large animals. The product serves to rapidly restore serum calcium levels, which are often critically depleted during the onset of lactation. In the context of the Indian veterinary market, such formulations typically consist of calcium borogluconate, frequently fortified with magnesium and phosphorus to address complex metabolic syndromes and support neuromuscular and cardiac function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calbonate.